Clinical Data

Zemaira Purity

Zemaira is made in a state-of-the-art facility under strict, controlled conditions, and is purified from human plasma through a rigorous virus-removal and inactivation process. Because Zemaira is made from human blood, the risk of transmitting infectious agents cannot be completely eliminated.

Safety

Studies have shown that A₁AT augmentation therapy is safe.

In clinical studies of Zemaira, at least 5% of subjects reported adverse reactions related to treatment, including:

1. Headache
2. Sinusitis
3. Upper respiratory infection
4. Bronchitis
5. Fatigue
6. Increased cough
7. Fever
8. Injection-site bleeding
9. Nasal symptoms
10. Sore throat
11. Swelled blood vessels

Dosing and Administration

Dosing

• The recommended dose of Zemaira is 60 mg/kg body weight given once weekly

Administration

• Zemaira is administered into your vein at a dose recommended by your doctor
• The recommended dose should take approximately 15 minutes to infuse, but this may vary as the dose is based on your current weight
• Zemaira can be stored safely at room temperature
• You will need to mix your dose before administering. Your doctor or pharmacist will explain how